Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P E Crossen

Showing results (61-70 of 72) with videos related to

Pageof 8
Sort By:
The New Zealand Medical Journal|June 1, 1972
Clonal evolution in leukaemiaP E Crossen, J E Mellor, P C Vincent, et al.
Cancer Genetics and Cytogenetics|September 15, 1999
Identification of amplified genes in a patient with acute myeloid leukemia and double minute chromosomesP E Crossen, M J Morrison, P Rodley, et al.
Cancer Genetics and Cytogenetics|December 1, 1991
Complex karyotypic evolution in B-cell chronic lymphocytic leukemiaP E Crossen, S M Tully, M J Morrison, et al.
Genes, Chromosomes & Cancer|November 1, 1991
Molecular definition of interstitial deletions of chromosome 13 in leukemic cellsC M Morris, J M Cochrane, S M Benjes, et al.
Annales De Genetique|June 1, 1970
A case of acute leukemia with a rapidly changing chromosome constitutionF W Gunz, R B Ravich, P C Vincent, et al.
Journal of the National Cancer Institute|January 1, 1973
Relevance of the cytogenetic status in acute leukemia in adultsF W Gunz, B I Bach, P E Crossen, et al.
The American Journal of Medicine|January 1, 1971
The Sézary syndrome: cytogenetic studies and identification of the Sézary Cell as an abnormal lymphocyteP E Crossen, J E Mellor, A G Finley, et al.
Human Genetics|January 1, 1984
Familial thrombocytopenia associated with platelet autoantibodies and chromosome breakageF M Helmerhorst, D C Heaton, P E Crossen, et al.
Genes, Chromosomes & Cancer|September 1, 1993
Oligoclonal B-cell leukemia characterized by spontaneous cell division and telomere associationP E Crossen, S M Tully, S M Benjes, et al.
Leukemia|February 12, 1999
Clonally unrelated BCR-ABL-negative acute myeloblastic leukemia masquerading as blast crisis after busulphan and interferon therapy for BCR-ABL-positive chronic myeloid leukemiaR Manley, J Cochrane, M McDonald, et al.
Pageof 8

Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
The New Zealand Medical Journal|June 1, 1972
Clonal evolution in leukaemiaP E Crossen, J E Mellor, P C Vincent, et al.
Cancer Genetics and Cytogenetics|September 15, 1999
Identification of amplified genes in a patient with acute myeloid leukemia and double minute chromosomesP E Crossen, M J Morrison, P Rodley, et al.
Cancer Genetics and Cytogenetics|December 1, 1991
Complex karyotypic evolution in B-cell chronic lymphocytic leukemiaP E Crossen, S M Tully, M J Morrison, et al.
Genes, Chromosomes & Cancer|November 1, 1991
Molecular definition of interstitial deletions of chromosome 13 in leukemic cellsC M Morris, J M Cochrane, S M Benjes, et al.
Annales De Genetique|June 1, 1970
A case of acute leukemia with a rapidly changing chromosome constitutionF W Gunz, R B Ravich, P C Vincent, et al.
Journal of the National Cancer Institute|January 1, 1973
Relevance of the cytogenetic status in acute leukemia in adultsF W Gunz, B I Bach, P E Crossen, et al.
The American Journal of Medicine|January 1, 1971
The Sézary syndrome: cytogenetic studies and identification of the Sézary Cell as an abnormal lymphocyteP E Crossen, J E Mellor, A G Finley, et al.
Human Genetics|January 1, 1984
Familial thrombocytopenia associated with platelet autoantibodies and chromosome breakageF M Helmerhorst, D C Heaton, P E Crossen, et al.
Genes, Chromosomes & Cancer|September 1, 1993
Oligoclonal B-cell leukemia characterized by spontaneous cell division and telomere associationP E Crossen, S M Tully, S M Benjes, et al.
Leukemia|February 12, 1999
Clonally unrelated BCR-ABL-negative acute myeloblastic leukemia masquerading as blast crisis after busulphan and interferon therapy for BCR-ABL-positive chronic myeloid leukemiaR Manley, J Cochrane, M McDonald, et al.
Pageof 8